Ozempic May Fight Alcohol and Opioid Addiction, Study Suggests

By joining, you agree to the Terms of Use and Privacy Plan & to get electronic interactions from VICE Media Group, which may include advertising and marketing promotions, ads and sponsored content.

By registering, you agree to the Regards to Use and Personal Privacy Policy & to get digital interactions from VICE Media Group, which may include advertising and marketing promotions, advertisements and funded content.

Scientists found that individuals with opioid use problem (OUD) that are GLP-1 medications are 40 percent less likely to experience an overdose than people with the condition that do not take the medicine.

Ozempic and various other GLP-1 RAs connect with the brain’s mesolimbic system to decrease hunger and trigger satisfaction after consuming. The mesolimbic system also overlaps with the brain processes that govern addicting behaviors– which suggests that the drugs may change the reward-response pathways related to material use, as the research discovered.

When it involves alcohol usage disorder (AUD), the outcomes are also better, with an alcohol drunkenness price that’s half reduced in people that take Ozempic. (To be clear, the data measured the number of “alcohol drunkenness occasions” instead of alcohol intake itself.).

All told, the research study checked out 500,000 individuals with OUD and upwards of 800,000 individuals with AUD. Scientists claim it could introduce a promising brand-new therapy for addicts, particularly for people with existing metabolic problems that might otherwise gain from GLP-1 agonists.

Ozempic may have even more uses than at first thought. A new research that showed up in the clinical journal Addiction located that GIP/GLP -1 receptor agonist drugs, traditionally utilized to deal with diabetes mellitus and advertise weight management, may likewise aid people quit using medications and drinking alcohol.